Effect of simvastatin on ejection fraction in cardiac transplant recipients

The American Journal of Cardiology
G H JenkinsD R Singer

Abstract

In a prospective observational study, we looked at the effects of simvastatin on cardiac function, lipids, and blood pressure after cardiac transplantation. Our study suggests that simvastatin treatment is associated with improved ejection fraction in cardiac transplant recipients independent of effects attributable to the lipid profile.

References

Jan 1, 1992·Clinical and Experimental Hypertension. Part A, Theory and Practice·B DahlöfL Hansson
Feb 1, 1990·Nature·J L Goldstein, M S Brown
Sep 1, 1981·Circulation·O de DivitiisM Mancini
Nov 13, 1980·The New England Journal of Medicine·S PortR H Jones
Oct 1, 1995·British Heart Journal·J ParameshwarS Large
Sep 7, 1995·The New England Journal of Medicine·J A KobashigawaG A Cogert
Nov 1, 1993·Journal of Clinical Immunology·R McPhersonH F Pross
Feb 8, 1996·The New England Journal of Medicine·K T Swanson

❮ Previous
Next ❯

Citations

Oct 12, 2010·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Szu-Chia ChenHung-Chun Chen
Jan 5, 2002·Expert Opinion on Investigational Drugs·S A Doggrell
Nov 26, 2009·American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions·Abhimanyu BeriSnigdha B Mahajan

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Diseases: Risk Factors

Cardiovascular disease is a significant health concern. Risk factors include hypertension, obesity, dyslipidemia and smoking. Women who are postmenopausal are at an increased risk of heart disease. Here is the latest research for risk factors of cardiovascular disease.